EMA to review sotagliflozin as potential treatment for type 1 diabetes
The European Medicines Agency (EMA) has accepted for review Sanofi's regulatory submission for sotagliflozin. If approved, the oral treatment would be used as an add...
Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.
Continue readingExploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.
Continue readingExploring emerging approaches to neurodegenerative disease research and treatment.
Continue readingHighlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.
Continue readingAdvertisement
Advertisement
Advertisement
Advertisement
Advertisement